- 专利标题： ANTIGEN PRESENTING CELL/TARGET CELL HYBRIDOMA-DERIVED VACCINES
-
申请号： US18684155申请日： 2022-08-19
-
公开(公告)号： US20240358830A1公开(公告)日： 2024-10-31
- 发明人: Young Jik Kwon , Jee Young Chung
- 申请人： THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- 申请人地址： US CA Oakland
- 专利权人： THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- 当前专利权人： THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- 当前专利权人地址： US CA Oakland
- 国际申请： PCT/US2022/040963 2022.08.19
- 进入国家日期： 2024-02-15
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61K35/15 ; A61K39/39 ; A61P35/00 ; C12N5/16
摘要：
The disclosure provides compositions, preparations, and methods comprising cell-derived vesicles induced using a blebbing agent from a hybridoma of a dendritic cell and a target cell, and uses thereof, including as a means to modulate a subject's immune system.
信息查询
